Enteric colibacillosis often affects over 50% of newborn calves in a herd, and death rates of 10 to 20% are common. The disease syndrome is characterized by a profuse watery diarrhea, severe dehydration, apathy, and hypothermia. The disease is treated with antibacterial drugs and intravenous administration of electrolyte solutions. Treatment is often ineffective, due in part to the presence of drug-resistant strains of Escherichia coli and failure to identify the drug susceptibility pattern of the strain involved.
In the present experiment, enteropathogenic E. coli strain B44 was used to induce enteric colibacillosis in newborn calves. Strain B44 was previously shown to cause distention of the rabbit and calf-ligated intestinal segment and to cause severe enteric colibacillosis when given orally to newborn colostrum-fed calves (5, 7) . A heat-stable enterotoxin elaborated by strain B44 was shown to be dialyzable (3) and to cause a net increase in secretion of fluid and certain electrolytes from the blood into the small intestine of the calf (2) .
It was previously reported (5) that vaccination of the dam prior to calving was effective in prevention of severe enteric colibacillosis caused by oral inoculation of calves with viable strain B44. The vaccine was administered to the dam by both intramammary and subcutaneous routes in an attempt to stimulate a high level of 1 Paper no. 441, Journal series, Montana State University Agricultural Experiment Station. antibody in the colostrum. Presumably, antibodies produced in the dam after vaccination were transferred to the calf via the colostrum and thereby passively immunized the calf. The mechanism by which antibody functions in protection of the calf has not been established.
The objectives of the present experiment were to (i) further study the pathogenesis of the disease caused by strain B44, (ii) determine the effectiveness of vaccination of the dam only via the subcutaneous route, and (iii) study the duration of the immune response in dams vaccinated via the subcutaneous and intramammary routes 1 Preparation of vaccine. A killed, whole-cell vaccine was prepared by using strain B44 as previously described (5 (Table 1) . At each vaccination, each cow received 5 ml of vaccine with adjuvant and 4 ml of vaccine without adjuvant. The control cows (group 2) were given one subcutaneous injection of 5 ml of placebo with adjuvant and one injection of 4 ml of placebo without adjuvant via the intramammary route (1 ml/quarter). Cows in group 3 were given 5 ml of vaccine with adjuvant subcutaneously and 4 ml of vaccine without adjuvant via the intramammary route (1 ml/quarter). In group 3, four cows received live whole cells, three killed whole cells, and four broth culture supernatant vaccine, which had been administered in the earlier experiment. Cows in group 4 were either not vaccinated or were given a placebo. In group 4, three cows received live whole cells, four killed whole cells, and four broth culture supernatant vaccine, which had been administered in the earlier experiment.
Challenge inoculation of calves with strain B44. The time of parturition was established by observing the cows at 3-to 4-h intervals. All calves were given oral challenge inoculation at 10 to 12 h of age with an 8-to 24-h-old culture of strain B44. The HIB culture (10 ml) containing about 3 x 1010 viable cells/ml was diluted to 50 ml with HIB and given orally to the calf. All calves appeared healthy and were free of diarrhea at the time challenge inoculation was given. Calves and dams were kept together to ensure intake of colostrum prior to challenge inoculation of the calf.
Pathogenesis of disease after chalienge inoculation of calves. The time of onset, duration, and severity of clinical signs of enteric colibacillosis after oral inoculation was determined for each calf by using criteria previously reported (5 (5) .°T hree heifers in group 1 and four heifers and one cow in group 2 were not in the earlier experiment and therefore were not vaccinated or given a placebo. All other cows (32) were present in the earlier experiment.
the calves were treated intravenously with electrolyte solution after reaching a 4+ condition. Calves were removed from the experiment after reaching a 4+ condition, after the cessation of diarrhea or, in the case of calves that did not have diarrhea, two days after challenge inoculation.
RESULTS
Protection results. Seven of eight control calves (group 2) developed severe enteric colibacillosis (4+ score) after challenge inoculation ( Clinically, calves which were given a score of 4+ had profuse, watery diarrhea initially, followed by progressive dehydration (as evidenced by sunken eyes and decrease in normal skin pliability), apathy, and hypothermia. In addition, calves given a 4+ score became too weak to stand, and some were prostrate at the time of treatment. Four calves that reached a 4+ condition died, either because they were not treated or treatment was ineffective. At necropsy, no significant gross pathological changes were seen, with the exception of one calf that had enteritis of the ileum. This calf and two other calves passed blood-tinged feces during the time they had diarrhea. DISCUSSION Results of the present experiment indicate that (i) calves are protected against severe enteric colibacillosis caused by strain B44 after homologous vaccination of the dam via the subcutaneous route, (ii) passive immunity is received by the calf born at least one year after homologous vaccination of the dam via the intramammary and subcutaneous routes, and (iii) although calves are protected against severe enteric colibacillosis by vaccination of the dams, they are often not protected from a transient diarrhea that, in some calves, is profuse and watery and indistinguishable from the diarrhea present early in the disease syndrome of calves that are not protected. This experiment confirmed the results reported earlier that strain B44 causes severe enteric colibacillosis characterized by profuse, watery diarrhea, severe dehydration, apathy, and hypothermia. Death may occur 18 to 48 h after onset of diarrhea.
There was no apparent correlation between age of the cow and susceptibility of the calf to enteric colibacillosis. It appeared that the larger calves (calf weight varied from about 23 to 37 kg) generally exhibited clinical signs of disease for a longer time before reaching a 4+ score than did the smaller calves. Apparently cow no. 24 (group 3) responded poorly to vaccination, because the calf obtained each year from this cow reached a 4+ score after challenge inoculation with strain B44.
Prior natural exposure of the dam to strain B44 apparently did not result in transfer of passive immunity to the calf the following year as indicated by the results in which two of three calves from cows no. 28, 32, and 36 reached a 4+ condition. These were the only three cows present in both experiments and not vaccinated in either one.
Results in the present experiment indicate that subcutaneous vaccination alone was comparable in effectiveness to vaccination via subcutaneous and intramammary routes. The duration of immunity after subcutaneous vaccination alone has not been studied.
A protective level of antibody was apparently present in the colostrum of dams that were given homologous vaccination via the intramammary and subcutaneous routes 1 year earlier (group 4). The calf was protected whether the dam had received live or killed whole cells or the broth culture supernatant vaccine. The effectiveness of vaccination via the intramammary route alone has not been established. It has been reported (9) that an elevated level of specific, indirect hemagglutinating antibody activity was present in the milk or one quarter of a cow for at least 464 days after homologous vaccination directly into that quarter with an E. coli vaccine. Vaccination via the intramammary route also caused an increase in specific antibody in the serum (8) . The concentration of protective antibody in the blood of the dam may be important in passive immunization of the calf, since it is known that maternal antibodies from the blood are concentrated in the colostrum prior to birth of the calf (1) .
The feasibility of vaccination against field cases of enteric colibacillosis has not been established. The disease is of greatest importance in calves less than 1 month of age. Antibody concentration in mammary secretions decreases rapidly within a few days after birth (6) . There is also a gradual decrease in the concentration of antibody in the blood of the calf during the first few weeks of life (4). More information is needed concerning the duration and mechanism of passive immunity in calves from vaccinated dams. Prevention of field outbreaks of enteric colibacillosis may also be dependent upon the acquisition of more information concerning strains of enteropathogenic E. coli present in nature.
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